Alkermes plc.
$7.66B- Market cap
- $7.73B
- Debt
- +$317.13M
- Cash
- −$388.57M
Capital structure 96% equity / 4% debt · EV / Revenue 5.19x · EV / EBITDA 23.76x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $7.73B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: ALKS stock price at premium vs MNST $46.10 current versus $32.21 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MNST's multiple
Implied fair value · at ALKS's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALKS FY 2025 (ended Dec 31, 2025) · MNST FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 96% equity / 4% debt · EV / Revenue 5.19x · EV / EBITDA 23.76x
Capital structure 98% equity / 2% debt · EV / Revenue 4.94x · EV / EBITDA 16.35x
MNST carries the larger enterprise value at $41.00B against $7.66B; MNST trades on the lower EV / Revenue multiple (4.94x vs 5.19x); MNST on the lower EV / EBITDA (16.35x vs 23.76x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Alkermes plc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Monster Beverage Corp · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.17x
0.10x
Net debt / EBITDA
Leverage against operating earnings
-0.22x
-0.77x
Cash and equivalents
Liquid reserves on the balance sheet
$388.57M
$2.77B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Jazz Pharmaceuticals plc
ALKS vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
ALKS vs SUPN
Amneal Pharmaceuticals, Inc.
ALKS vs AMRX
COCA COLA CO
ALKS vs KO
PEPSICO INC
ALKS vs PEP
Keurig Dr Pepper Inc.
ALKS vs KDP
NATIONAL BEVERAGE CORP
ALKS vs FIZZ
MOLSON COORS BEVERAGE CO
ALKS vs TAP
BROWN FORMAN CORP
ALKS vs BF-A
$317.13M
$842.99M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.